JVC Investment Partners focuses on investing in growth platforms within the healthcare industry, particularly targeting low middle-market companies. They typically engage in Series A investment rounds, providing significant capital to help businesses scale and achieve their growth potential.

Notable portfolio companies include Immpact Bio, which has raised $18 million. The firm is led by founder David N. Jonas, who brings extensive experience in forming and partnering with businesses across various sectors. JVC Investment Partners emphasizes investing their own capital in visionary entrepreneurs and innovative technologies, offering strategic support and resources to help their portfolio companies thrive.